MTOR and hepatocellular carcinoma: In HCC cell lines, such as MHCC97H and PLC/RLF/5, the upregulated NT5DC2-induced overexpression of EGFR and the activation of the downstream PI3K/AKT/mTOR signaling pathway occurs [32].